Dynamic Characteristics of Serum Hepatitis B Surface Antigen in Chinese Chronic Hepatitis B Patients Receiving 7 Years of Entecavir Therapy

BACKGROUND: The ultimate goal of hepatitis B treatment is hepatitis B surface antigen (HBsAg) seroclearance. Several factors have been suggested to be associated with the rate of HBsAg reduction in antiviral-naive or lamivudine therapy cohorts. However, there are few studies evaluating the factors d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xia-Xia, Li, Min-Ran, Xi, Hong-Li, Cao, Ying, Zhang, Ren-Wen, Zhang, Yu, Xu, Xiao-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831527/
https://www.ncbi.nlm.nih.gov/pubmed/27064037
http://dx.doi.org/10.4103/0366-6999.179802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831527/
https://www.ncbi.nlm.nih.gov/pubmed/27064037
http://dx.doi.org/10.4103/0366-6999.179802

Ejemplares similares